Clinical Study

Retreatment of Patients Nonresponsive to Pegylated Interferon and Ribavirin with Daily High-Dose Consensus Interferon

Table 1

Demographics and baseline data.

Patient CharacteristicResults

Ethnicity
 Caucasian61.5%
 Hispanic30.8%
 African-American7.7%

Weight (kilograms)
 Mean ± SEM
 Stage 1-23
 Stage 35
 Stage 45

Response to prior treatment ( )
 Null response10
 Partial response3

WBC count ( )
 Mean SEM
Hemoglobin ( )
Platelet count ( )

Fibrosis stage defined as modified Ishak score determined as defined by Theise [10].